Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed in the page footer, indicating an administrative version update. This change does not affect study details, navigation, or user actions.SummaryDifference0.1%

- Check26 days agoChange DetectedDeleted the administrative notice about potential data delays due to funding lapses and the related links to cc.nih.gov and opm.gov for operating status.SummaryDifference0.4%

- Check49 days agoChange DetectedThe two screenshots show no changes to core content or functionality of the study page; only minor formatting and layout adjustments were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference3%

- Check77 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top element has been removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.